Dis-Chem Pharmacies Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Dis-Chem Pharmacies ha aumentado sus beneficios a una tasa media anual de 10.6%, mientras que los beneficios de la industria de Consumer Retailing han experimentado un crecimiento de 11.9% anual. Los ingresos han ido creciendo a una tasa media de 10.6% al año. La rentabilidad financiera de Dis-Chem Pharmacies es de 22%, y sus márgenes netos son de 2.6%.

Información clave

10.6%

Tasa de crecimiento de los beneficios

10.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Consumer Retailing	8.2%
Tasa de crecimiento de los ingresos	10.6%
Rentabilidad financiera	22.0%
Margen neto	2.6%
Próxima actualización de resultados	31 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Dis-Chem Pharmacies. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

JSE:DCP Ingresos, gastos y beneficios (ZAR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Aug 23	34,191	899	1,006
31 May 23	33,427	949	1,006
28 Feb 23	32,664	1,000	1,006
30 Nov 22	32,231	1,020	915
31 Aug 22	31,798	1,040	824
31 May 22	31,102	946	824
28 Feb 22	30,407	853	824
30 Nov 21	29,407	815	2,894
31 Aug 21	28,407	776	4,964
31 May 21	27,343	722	4,964
28 Feb 21	26,278	669	4,964
30 Nov 20	25,611	655	4,506
31 Aug 20	24,944	641	4,049
31 May 20	24,464	620	4,049
29 Feb 20	23,984	598	4,049
30 Nov 19	23,394	573	3,748
31 Aug 19	22,803	549	3,448
31 May 19	22,111	634	3,448
28 Feb 19	21,420	719	3,448
30 Nov 18	20,898	718	3,239
31 Aug 18	20,376	718	3,031
31 May 18	19,928	701	3,031
28 Feb 18	19,480	684	3,031
30 Nov 17	18,919	715	2,831
31 Aug 17	18,359	746	2,631
31 May 17	17,814	679	2,631
28 Feb 17	17,268	612	2,631
30 Nov 16	16,794	548	1,577
31 Aug 16	16,320	484	524
31 May 16	15,691	498	524
29 Feb 16	15,061	513	524
28 Feb 15	12,911	434	2,321
28 Feb 14	10,321	409	1,834

Ingresos de calidad: DCP tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(2.6%) de DCP son inferiores a los del año pasado (3.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de DCP han crecido un 10.6% al año en los últimos 5 años.

Acelerando crecimiento: DCP ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: DCP tuvo un crecimiento negativo de los beneficios (-13.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Consumer Retailing (-3.8%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera (22%) de DCP se considera alta.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Dis-Chem Pharmacies Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Dis-Chem Pharmacies Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

First half 2024 earnings released: EPS: R0.58 (vs R0.70 in 1H 2023)

Full year 2023 earnings: EPS misses analyst expectations

Dis-Chem Pharmacies Limited to Report Fiscal Year 2023 Results on May 19, 2023

Dis-Chem Pharmacies Limited to Report First Half, 2023 Results on Nov 02, 2022

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Recent updates

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Now 20% overvalued after recent price rise

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dis-Chem Pharmacies Limited, Annual General Meeting, Jul 31, 2024

Upcoming dividend of R0.23 per share at 1.4% yield

Price target increased by 11% to R27.72

First half 2024 earnings released: EPS: R0.58 (vs R0.70 in 1H 2023)

Dis-Chem Pharmacies Limited(JSE:DCP) dropped from FTSE All-World Index (USD)

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Dis-Chem Pharmacies Limited (JSE:DCP) acquired Berea Pharmacy.

Upcoming dividend of R0.18 per share at 1.6% yield

Price target decreased by 7.6% to R27.38

Full year 2023 earnings: EPS misses analyst expectations

Dis-Chem Pharmacies Limited Announces Gross Final Cash Dividend for the Period Ended 28 February 2023, Payable from 12 June 2023

Dis-Chem Pharmacies Limited Announces Executive Changes, Effective July 1, 2023

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Price target decreased by 8.5% to R31.10

Price target decreased by 9.6% to R33.00

Dis-Chem Pharmacies Limited to Report Fiscal Year 2023 Results on May 19, 2023

Executive Director exercised options to buy R96k worth of stock.

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

High number of new directors

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited to Report First Half, 2023 Results on Nov 02, 2022

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Now 20% undervalued

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Insider recently sold R25m worth of stock

Insider recently sold R10m worth of stock

Now 20% undervalued after recent price drop

High number of new directors

Now 20% undervalued after recent price drop

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Upcoming dividend of R0.20 per share

Dis-Chem Pharmacies Limited Declares Final Dividend for the Financial Year 2022

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Dis-Chem Pharmacies Limited Declares Final Dividend for the Financial Year 2022

Full year 2022 earnings: Revenues in line with analyst expectations

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Alternate Executive Director recently sold R47m worth of stock

Dis-Chem Pharmacies Limited to Report Fiscal Year 2022 Results on May 23, 2022

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Insider recently sold R183m worth of stock

High number of new directors

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Insider recently sold R60m worth of stock

Upcoming dividend of R0.19 per share

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

First half 2022 earnings released: EPS R0.48 (vs R0.36 in 1H 2021)

Dis-Chem Pharmacies Limited (JSE:DCP) acquired Medicare Hospital Equipment (Pty) Ltd from existing shareholders.

Royal Bafokeng Holdings (Pty) Limited, Global Capital Empowerment Fund, Zungu Pharmaceuticals and Temo Capital completed the acquisition of 10.05% stake in Dis-Chem Pharmacies Limited (JSE:DCP) from Saltzman Family Trust.

Full year 2021 earnings released: EPS R0.78 (vs R0.70 in FY 2020)

Independent Non-Executive Director recently sold R2.5m worth of stock

Price target increased to R29.07

Upcoming dividend of R0.31 per share

Full year 2021 earnings released: EPS R0.78 (vs R0.70 in FY 2020)

Dis-Chem Pharmacies Limited Announces Company Secretary Change

Company Secretary has left the company

New 90-day high: R23.69

Dis-Chem Pharmacies Limited to Report Fiscal Year 2021 Results on May 21, 2021

Insider recently sold R23m worth of stock

Desglose de ingresos y gastos
Beta